Alterity Therapeutics Statistics

Total Valuation

ATHE has a market cap or net worth of $10.36 million. The enterprise value is $2.26 million.

Market Cap	10.36M
Enterprise Value	2.26M

Important Dates

The next estimated earnings date is Tuesday, December 3, 2024, after market close.

Earnings Date	Dec 3, 2024
Ex-Dividend Date	n/a

Share Statistics

ATHE has 5.32 billion shares outstanding. The number of shares has increased by 50.29% in one year.

Current Share Class	n/a
Shares Outstanding	5.32B
Shares Change (YoY)	+50.29%
Shares Change (QoQ)	+91.53%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.70B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	1.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.01.

Current Ratio	3.54
Quick Ratio	3.10
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -104.47% and return on invested capital (ROIC) is -66.27%.

Return on Equity (ROE)	-104.47%
Return on Assets (ROA)	-52.66%
Return on Capital (ROIC)	-66.27%
Revenue Per Employee	$268,167
Profits Per Employee	-$1.28M
Employee Count	10
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

In the past 12 months, ATHE has paid $30,750 in taxes.

Income Tax	30,750
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.88% in the last 52 weeks. The beta is 0.68, so ATHE's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-55.88%
50-Day Moving Average	1.23
200-Day Moving Average	1.67
Relative Strength Index (RSI)	34.63
Average Volume (20 Days)	12,009

Short Selling Information

Short Interest	3,574
Short Previous Month	6,216
Short % of Shares Out	0.04%
Short % of Float	n/a
Short Ratio (days to cover)	0.32

Income Statement

In the last 12 months, ATHE had revenue of $2.68 million and -$12.76 million in losses. Loss per share was -$0.00.

Revenue	2.68M
Gross Profit	2.54M
Operating Income	-13.08M
Pretax Income	-8.09M
Net Income	-12.76M
EBITDA	-13.06M
EBIT	-13.08M
Loss Per Share	-$0.00

Full Income Statement

Balance Sheet

The company has $8.43 million in cash and $106,115 in debt, giving a net cash position of $8.33 million or $0.00 per share.

Cash & Cash Equivalents	8.43M
Total Debt	106,115
Net Cash	8.33M
Net Cash Per Share	$0.00
Equity (Book Value)	9.21M
Book Value Per Share	0.00
Working Capital	9.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.41 million and capital expenditures -$3,818, giving a free cash flow of -$8.21 million.

Operating Cash Flow	-8.41M
Capital Expenditures	-3,818
Free Cash Flow	-8.21M
FCF Per Share	-$0.00

Full Cash Flow Statement

Margins

Gross Margin	94.67%
Operating Margin	-487.82%
Pretax Margin	-474.65%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATHE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.29%
Shareholder Yield	-50.29%
Earnings Yield	-123.20%
FCF Yield	-79.30%

Analyst Forecast

The average price target for ATHE is $4.00, which is 280.95% higher than the current price. The consensus rating is "Buy".

Price Target	$4.00
Price Target Difference	280.95%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 9, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jan 9, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

ATHE has an Altman Z-Score of -15.68 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.68
Piotroski F-Score	2